Platelet-rich Plasma and Mesenchymal Stem Cells: Exciting, But … are we there Yet?

Sports Med Arthrosc Rev. 2018 Jun;26(2):59-63. doi: 10.1097/JSA.0000000000000191.

Abstract

Joint conditions incapacitate free movement driving to a sedentary lifestyle, a major risk factor for chronic diseases. Regenerative procedures, involving the use of mesenchymal stem/stromal cells along with platelet-rich plasma (PRP), can help patients with these conditions. We describe the main characteristics of cellular products (bone marrow concentrate, stromal vascular fraction of adipose tissue, and mesenchymal stem/stromal cells derived from these tissues), and the potential benefits of combination with PRP in 3 scenarios: PRP lysates used during laboratory cell expansion; PRP to prime cellular products or the host tissue before cell implantation; PRP used as a vehicle for cell transplantation and to provide trophic signals. Clinical studies exploring the benefits of combination products are limited to case series and few controlled studies, involving either arthroscopy or percutaneous injections. Combination products are making their way to clinics but further experimental and clinical research is needed to establish protocols and indications.

Publication types

  • Review

MeSH terms

  • Adipose Tissue / cytology
  • Cell Proliferation
  • Cell- and Tissue-Based Therapy / trends*
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells / cytology
  • Platelet-Rich Plasma*